RxDoctor Payments Data

Ankur Manvar, MD

Pain Medicine · Charlotte, NCNPI 1598025983

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $22,778 of the $33,363 with a category attached, or 68.3%. It is spread thinly across 37 manufacturers, the largest accounting for just 20.7%. Among pain medicine clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$33,363in general payments, 2019–2025

Across 686 payments — averaging $48.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$7K
  • Boston Scientific$4K
  • Nevro Corp.$4K
  • SPR Therapeutics, Inc$4K
  • Forte Bio-pharma LLC$3K
  • Medtronic$3K
  • plus $9K from 31 others

What the payments were for

  • Consulting fees$1,7505%
  • Speaking & faculty fees$1,5004%
  • Travel & lodging$7,33022%
  • Food & beverage$22,77868%
  • Education$50%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$33,363 in reported general payments places this provider in the 90th percentile of 182 pain medicine providers in North Carolina.

See all pain medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$454,093
Medicare patients
343
Services billed
8,024

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen142$103,138
HorizantGabapentin Enacarbil35$35,244
ZtlidoLidocaine42$29,996
GraliseGabapentin25$23,044
Pregabalin693$18,890
Gabapentin734$15,810
Duloxetine Hcl174$3,845
Methocarbamol160$3,156
Lidocaine13$1,359
Celecoxib90$1,188
Meloxicam308$1,079
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen58$961
Diclofenac Sodium27$838
Tizanidine Hcl46$619
Cyclobenzaprine Hcl25$358

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Scilex Pharmaceuticals Inc.Ztlido$377$29,99642 claims
Almatica Pharma LLCGralise$188$23,04425 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 182 pain medicine providers in North Carolina.

Other pain medicine in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →